BMBruno Moulin

Bruno Moulin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bruno Moulin has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of a dedicated podcast on undergraduate nephrology learning: A Multicenter Cross-Sectional Study (Preprint)

    by Margaux Van Wynsberghe, Sandrine Lemoine, Lucile Figueres, Antoine Lanot, Bruno Moulin, Marie Pierre Tavolacci, Dany Anglicheau, Dominique Guerrot

    BACKGROUND Podcasts are increasingly used as flexible learning resources in medical education, but evidence regarding their educational effectiveness remains limited. NephrOdio is a freely accessible, curriculum-based nephrology podcast developed by the French College of Nephrology Academics and designed to complement conventional undergraduate nephrology teaching. Since its launch in 2023, the podcast has accumulated more than 700,000 downloads. OBJECTIVE To evaluate the use, perceived educational value, and association between NephrOdio use and nephrology examination performance among French undergraduate medical students. METHODS We conducted a multicenter cross-sectional study among undergraduate medical students from 16 French medical schools. Data on podcast use, educational perceptions, and academic performance were collected through a national survey. Nephrology examination performance was compared between NephrOdio users and non-users, and according to cumulative podcast exposure. Analyses were conducted in a pooled national cohort using self-reported examination scores and in an institutional validation cohort from Rouen University using objectively retrieved examination scores. RESULTS Among 758 students who completed the survey, 627 reported an available nephrology examination score. NephrOdio was the third most frequently used educational resource for nephrology, after the national textbook and examination question banks. Among users, 82% rated its overall educational value at 4 or 5 on a 5 point Likert scale, and 94% would recommend it to another medical student. NephrOdio users achieved higher nephrology examination scores than non-users (13.94 ± 0.09 vs. 12.72 ± 0.31, P< .001). Higher cumulative podcast exposure was associated with progressively higher examination performance. The association between podcast use and nephrology examination performance was also observed in the institutional validation cohort using objectively retrieved examination scores. CONCLUSIONS NephrOdio was widely adopted by French medical students and was associated with high perceived educational value and better nephrology examination performance. The consistency of the association across self-reported and objectively retrieved academic outcomes supports the potential value of curriculum-based podcasts as complementary resources for undergraduate medical education. These findings suggest that structured, freely accessible podcasts may provide a scalable approach to supporting nephrology learning.

  • Association of Complement Genetics with Outcomes in IgA Nephropathy

    by Anna Duval, Nicolas Maillard, Martin Morin, Carine El Sissy, Paula Vieira-Martins, Axelle Durand, Julia Roquigny, Maxime Lecerf, Sophie Chauvet, Jérôme Olagne, et al.

    Key Points: Activation of the alternative and lectin complement pathways contributes to disease severity and progression in IgA nephropathy. In this French cohort with severe IgA nephropathy, complement factor H CFH-H2 was underrepresented, and rare complement factor H missense variants were more frequent, affecting regulatory domains. Homozygosity for the membrane cofactor protein CD46 ggaac haplotype was associated with progression to ESKD, warranting confirmation in larger cohorts. Background: Complement activation plays a role in IgA nephropathy. Indeed, genome-wide association studies have identified a susceptibility locus for IgA nephropathy complement factor H ( CHF ) and its related proteins genes. However, the relationship between complement genetics and IgA nephropathy severity is not established. Methods: We sequenced 260 adults with a primary IgA nephropathy by next-generation sequencing of the CFH , complement factor I, complement factor B, membrane cofactor protein (encoded by CD46 ), C3 , and CFH related protein 5 genes. The frequencies of rare variants (minor allele frequency CFH , membrane cofactor protein, and complement factor B haplotypes were compared with the European population from the 1000 Genomes Project. Functional in vitro studies were performed on recombinant full-length CFH variants. Results: Our genetic analysis revealed a higher prevalence of rare CFH nonsynonymous variants in patients with IgA nephropathy compared with controls (5% versus 2%, P = 0.03). In vitro studies showed impaired complement regulatory activity for five variants. The CFH-H2 haplotype was associated with lower IgA nephropathy susceptibility (odds ratio, 0.52 [0.34 to 0.79], P = 0.03, dominant model). Moreover, multivariable analysis revealed that the homozygous CD46 ggaaac haplotype was associated with ESKD 15 years after diagnosis (hazard ratio, 2.83; 95% confidence interval, 1.20 to 6.68; P = 0.02). Conclusions: Our study shed light on the dual role of complement genetics in IgA nephropathy. Our exploratory findings strengthen the evidence for a role of complement genetics in IgA nephropathy but will need confirmation in larger and independent studies.


  • Open Access

    Extracellular Fluid Volume and Mortality after Kidney Transplantation

    by Melissa Ould Rabah, Lise Morin, Nassim Dali-Youcef, Guillaume Géri, Manal Mazloum, Nicolas Garcelon, Julien Husson, Malik Touam, Bruno Moulin, Sophie Caillard, et al.

    Key Points: Post-transplantation extracellular fluid volume (ECV) is not only influenced by recipient characteristics and allograft function, but also by transplantation-specific factors. In multivariable cause-specific Cox analyses, increased ECV 3 months after kidney transplantation is independently associated with all-cause mortality but not graft loss. Multivariable linear regression further identified increased 3-month ECV as an independent predictor of reduced GFR measurement at 12 months. Background: High extracellular fluid volume (ECV) is associated with an increased risk of death in nontransplanted patients with CKD. By contrast, both the determinants and the prognosis value of ECV in kidney transplant recipients remain unclear. Methods: We studied a bicentric prospective cohort of 2057 kidney transplant recipients who underwent GFR measurement (mGFR) 3 months after transplantation. We calculated ECV from iohexol plasma disappearance curve and analyzed its association with patient's characteristics and outcomes. Results: The mean ECV and mGFR were 14.6±2.6 L/1.73 m2 and 52±16 ml/min per 1.73 m2, respectively. Multiple linear regression identified male sex, older donor and recipient ages, deceased donor, nonpreemptive transplantation, diabetes, cardiac arrhythmia, heart failure, proteinuria, and higher mGFR as independent factors associated with increased ECV. In multivariable cause-specific Cox analyzes, higher tertiles of ECV were associated with increased mortality (tertile 1 as reference; hazard ratio [95% confidence interval] for tertile 2: 1.65 [1.11 to 2.47]; tertile 3: 1.80 [1.18 to 2.74]) but not graft loss. Increased ECV, 3 months after transplantation, was a predictor of reduced mGFR at 12 months after adjusting for 3-month mGFR and other confounding factors (β coefficient: −0.06; 95% confidence interval [−0.09 to −0.02]). Conclusions: An elevated ECV 3 months after kidney transplantation is independently associated with increased mortality and decreased mGFR at 12 months, but not with graft loss.


  • Open Access

    Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay

    by Romain Pszczolinski, Cécile Acquaviva, Insaf Berrahal, Nathalie Biebuyck, Stéphane Burtey, Karine Clabault, Claire Dossier, Matthieu Guillet, Floriane Hemery, Emmanuel Letavernier, et al.

    Primary hyperoxalurias (PH) are extremely rare genetic disorders characterized by clinical heterogeneity. Delay in diagnosing these conditions can have detrimental effects on patient outcomes. The primary objective of this study is to assess the current diagnostic delay for PH. This nationwide, observational and retrospective study included patients who received a genetic diagnosis of PH types 1, 2 and 3 between 1 January 2015 and 31 December 2019. Diagnostic delay was defined as the duration between the onset of symptoms and the time of genetic diagnosis. A total of 52 patients (34 children and 18 adults) were included in the study, with 40 PH1 (77%), 3 PH2 (6%) and 9 PH3 (17%). At the time of diagnosis, 12 patients (23%) required dialysis. Among the PH1 patients, the predominant symptom at onset in adults was renal colic (79% of cases), whereas symptoms in children were more diverse (renal colic in 17% of cases). The diagnostic delay was significantly shorter in children compared with adults [median (interquartile range)]: 1.2 (0.1–3.0) versus 30 (17–36) years, respectively (P < .0001). RNA interference was utilized in 23 patients (58%). Five individuals (13%) underwent double liver–kidney transplantation, and five (13%) received isolated kidney transplantation, with lumasiran therapy in four patients. For PH2 and PH3 patients, the diagnostic delay ranges from 0 to 3 years, with renal colic as first symptom in 33% of cases. This extensive and recent cohort of PH underscores the considerable delay in diagnosing PH, particularly in adults, even in a country with a dedicated organization for enhancing the overall management of rare diseases. These findings reinforce the imperative for increased awareness among relevant specialties regarding the evaluation of urolithiasis.


  • Open Access

    Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation

    by Anna Duval, Jérôme Olagne, Augustin Obrecht, Gabriela Gautier Vargas, Peggy Perrin, Bruno Moulin, Véronique Frémeaux-Bacchi, Sophie Caillard


  • Open Access

    A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome

    by David Marx, Arnaud Dupuis, Anita Eckly, Anne Molitor, Jérôme Olagne, Guy Touchard, Sihem Kaaki, Cécile Ory, Anne-Laure Faller, Bénédicte Gérard, et al.

    While loss-of-function variants in the WAS gene are associated with Wiskott-Aldrich syndrome and lead to microthrombocytopenia, gain-of-function variants of WAS are associated with X-linked neutropenia (XLN) and the absence of microthrombocytopenia. Only a few XLN families have been reported so far, and their platelet phenotype was not described in detail. To date, no renal involvement was described in XLN. In the present study, we report exome sequencing of individuals from 3 generations of a family with a dominant disease combining neutropenia, macrothrombocytopenia, and renal failure. We identified a heterozygous missense gain-of-function variant in the WAS gene (c.881T>C, p.I294T) that segregates with the disease and is already known to cause XLN. There was no pathogenic variant in MYH9, TUBB1, or ACTN1. This is the first report of a WAS gain-of-function variant associated with both the hematological phenotype of XLN (neutropenia, macrothrombocytopenia) and renal disease (proteinuria, renal failure) with glomerular tip lesion hyalinosis and actin condensations in effaced podocytes foot processes.


  • Open Access

    Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study

    by Benjamin Wyplosz, Jérôme Fernandes, Ariane Sultan, Nicolas Roche, François Roubille, Paul Loubet, Bertrand Fougère, Bruno Moulin, Didier Duhot, Alexandre Vainchtock, et al.


  • Open Access

    Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study

    by Ilies Benotmane, Gabriela Gautier-Vargas, Noëlle Cognard, Jérôme Olagne, Françoise Heibel, Laura Braun-Parvez, Jonas Martzloff, Peggy Perrin, Romain Pszczolinski, Bruno Moulin, et al.

    Kidney transplant recipients (KTRs) displays marked inter-individual variations in magnitude of immune responses to anti-SARS-CoV-2 vaccination. The aim of this large single-center study was to identify the predictive factors for serological response to the mRNA-1273 vaccine in KTRs. We also devised a score to optimize prediction with the goal of implementing a personalized vaccination strategy. The study population consisted of 564 KTRs who received at least two doses of the mRNA-1273 vaccine. Anti-RBD IgG titers were quantified one month after each vaccine dose and until six months thereafter. A third dose vaccine was given when the antibody titer after the second dose was p < 0.0001) and the occurrence of a good antibody response (AUC = 0.785, p < 0.0001). Notably, antibody titers declined over time both after the second and third vaccine doses. In summary, a high burden of comorbidities and immunosuppression was correlated with a weaker antibody response. A fourth vaccine dose and/or pre-exposure prophylaxis with monoclonal antibodies should be considered for KTRs who remain unprotected.


  • Open Access

    Urinary collagen-derived peptides as sensitive markers for bone resorption and bisphosphonate treatment in kidney transplant patients

    by David Marx, Dany Anglicheau, Sophie Caillard, Bruno Moulin, Audrey Kochman, Harald Mischak, Martin Pejchinowski, Agnieszka Latosinska, Frank Bienaimé, Dominique Prié, et al.

    Kidney transplant recipients (KTR) are at increased risk of fractures. Total urinary hydroxyproline excretion used to be a marker for bone resorption (BR) but faded into the background when more specific markers like Beta-CrossLaps (CTX) became available. Proteomic studies identified numerous hydroxyproline-containing urinary collagen peptides but their origin remains unknown. We followed the hypothesis that some of the urinary collagen peptides are associated with BR and are markers for pathophysiological changes in bone metabolism of KTR. Clinical and laboratory data including serum levels of CTX in 96 KTR from two French centers (Strasbourg, n=38; Paris-Necker, n=58) were correlated with the signal intensity of urinary peptides identified by capillary electrophoresis (CE) coupled to mass spectrometry (MS) and tandem-MS. The effect of oral bisphosphonates on urinary peptides was studied in an independent group of 11 KTR. Eighty-two urinary peptides were identified to be significantly correlated with serum CTX levels in both cohorts. Statistical association with parameters other than BR markers were not significant. Collagen α-1(I) chain (COL1A1) was the most frequently identified peptide source. COL1A1 peptides associated with BR were significantly more hydroxylated than those showing no association (55.9% versus 45,2%, p2 -test). From the 82 urinary peptides correlated to CTX, 17 were significantly associated with bisphosphonate treatment. All of these 17 peptides showed a marked reduction in their excretion levels after 410 ± 344 days of bisphosphonate treatment compared to baseline levels. We studied the cleavage sites of these COL1A1 peptides and observed a signature of Cathepsin K and Matrix Metallopeptidase 9. This study provides strong evidence for the occurrence of collagen peptides in the urine of KTR that are associated with BR and that are sensitive to bisphosphonate treatment. Their assessment might become a valuable tool to monitor bone status in KTR.


  • High‐flow arteriovenous fistula and hemodynamic consequences at 1 year after kidney transplantation

    by Nicolas Keller, Alexandra Monnier, Sophie Caillard, Noëlle Cognard, Bernard Geny, Bruno Moulin, Samy Talha

    Introduction: There are only scarce data regarding the cardiovascular impact of arteriovenous fistula after kidney transplantation depending on fistula flow.Methods: We performed a single‐center, prospective, cohort study including 49 patients with a functional fistula at 1 year from kidney transplantation. Patients were convened for a clinical work‐up, a biological analysis, a fistula's Doppler ultrasonography and an echocardiography. Main judgment criterion was comparison of echocardiography parameters between patients with relative (fistula flow >1 L/min and a fistula flow/cardiac output ratio >20%), absolute high‐flow fistula (fistula flow >2 L/min) and normal‐flow fistula.Results: High‐flow fistula frequency was 69%. Significantly higher left ventricular end‐diastolic and systolic diameters were observed in this group compared with the normal‐flow fistula group (53 ± 6 vs. 48 ± 7 mm; p = 0.04 and 33 ± 6 vs. 28 ± 8 mm; p = 0.02) and between the absolute and relative high‐flow fistula subgroups (56 ± 6 vs. 51 ± 6 mm; p = 0.009 and 35 ± 6 vs. 31 ± 5 mm; p = 0.01). The study showed no other significant differences.Conclusions: This study showed a significantly higher but not pathological left ventricular end‐diastolic and systolic diameters values in patients with high‐flow fistula compared with patients with normal‐flow fistula and between patients with respectively absolute and relative high‐flow fistula.